Clinical Trial Update: Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma [Phase 1]

View source ↗

Summary

A Phase 1 pilot study tested the safety of bone marrow-derived stem cells in patients with glioblastoma; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bone marrow-derived stem cells

Snippet

Sponsor: Henry Friedman | Conditions: Grade IV Malignant Glioma | Phase 1 | Status: COMPLETED